References: Treatment of heparin-induced thrombocytopenia

  • Joseph J, Rabbolini D, Enjeti AK, Favaloro E, Kopp MC, McRae S, et al. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group. Med J Aust 2019;210(11):509-16. https://www.ncbi.nlm.nih.gov/pubmed/31155728
  • Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e495S-e530S. https://www.ncbi.nlm.nih.gov/pubmed/22315270
  • Tsu LV, Dager WE. Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia. Pharmacotherapy 2012;32(1):20-6. https://www.ncbi.nlm.nih.gov/pubmed/22392825